Regeneron Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
18 Dezembro 2023 - 6:05PM
Regeneron Pharmaceuticals, Inc. (NASDAQ:
REGN)
will webcast its presentation at the 42nd Annual J.P. Morgan
Healthcare Conference on Monday, January 8, 2024. The presentation
is scheduled for 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time)
and may be accessed from the "Investors & Media" page of
Regeneron's website at
http://investor.regeneron.com/events-and-presentations. A replay
and transcript of the webcast will be archived on the Company's
website for at least 30 days.
About RegeneronRegeneron is a leading
biotechnology company that invents, develops, and commercializes
life-transforming medicines for people with serious diseases.
Founded and led for 35 years by physician-scientists, Regeneron's
unique ability to repeatedly and consistently translate science
into medicine has led to numerous FDA-approved treatments and
product candidates in development, almost all of which were
homegrown in Regeneron's laboratories.Regeneron's medicines and
pipeline are designed to help patients with eye diseases, allergic
and inflammatory diseases, cancer, cardiovascular and metabolic
diseases, hematologic conditions, infectious diseases, and
rare diseases.
Regeneron is accelerating and improving the traditional drug
development process through its
proprietary VelociSuite® technologies, such
as VelocImmune®, which uses unique genetically
humanized mice to produce optimized fully
human antibodies and bispecific antibodies, and through
ambitious research initiatives such as the Regeneron Genetics
Center®, which is conducting one of the largest genetics sequencing
efforts in the world.
For additional information about Regeneron, please
visit www.regeneron.com or follow Regeneron on
LinkedIn.
Contact Information:Investor RelationsRyan
Crowe914.847.8790ryan.crowe@regeneron.com
Corporate CommunicationsChristina
Chan914.847.8827christina.chan@regeneron.com
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024